These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20883943)

  • 1. Interventional cardiology live case presentations: regulatory considerations.
    Farb A; Brown SA; Wolf DA; Zuckerman B
    J Am Coll Cardiol; 2010 Oct; 56(15):1283-5. PubMed ID: 20883943
    [No Abstract]   [Full Text] [Related]  

  • 2. Interventional cardiology live case presentations: regulatory considerations.
    Farb A; Brown SA; Wolf DA; Zuckerman B
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):E126-9. PubMed ID: 20862708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional cardiology live case presentations regulatory considerations.
    Farb A; Brown SA; Wolf DA; Zuckerman B
    Heart Rhythm; 2010 Oct; 7(10):e1-3. PubMed ID: 20869626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS.
    Di Mario C
    EuroIntervention; 2011 Mar; 6(8):913, 915-7. PubMed ID: 21330236
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions.
    Beekman RH; Duncan BW; Hagler DJ; Jones TK; Kugler JD; Moore JW; Jenkins KJ;
    Pediatrics; 2009 Jul; 124(1):e155-62. PubMed ID: 19564262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality and appropriateness of care: the response to allegations and actions needed by the cardiovascular professional.
    Brindis RG; Goldberg SD; Turco MA; Dean LS
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):2-4. PubMed ID: 21181966
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: The risk of over-regulation.
    Di Mario C; James S; Dudek D; Sabate M; Degertekin M
    BMJ; 2011 May; 342():d3021. PubMed ID: 21572138
    [No Abstract]   [Full Text] [Related]  

  • 8. Telecardiology: legal issues and new developments.
    Millman DS; Klesel AB
    Telemed Today; 1999 Jun; 7(3):27-9. PubMed ID: 10557540
    [No Abstract]   [Full Text] [Related]  

  • 9. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future.
    Dehmer GJ; Douglas JS; Abizaid A; Berg JW; Day J; Hall R; Leon MB; Hijazi ZM; Marchlinski F; Park SJ; Popma JJ; ; ; ; ; ; ;
    J Am Coll Cardiol; 2010 Oct; 56(15):1267-82. PubMed ID: 20883942
    [No Abstract]   [Full Text] [Related]  

  • 10. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the Past and Standards for the Future.
    Dehmer GJ; Douglas JS; Abizaid A; Berg JW; Day J; Hall R; Leon MB; Hijazi ZM; Marchlinski F; Park SJ; Popma JJ; ; ; ; ; ;
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):E111-25. PubMed ID: 20862709
    [No Abstract]   [Full Text] [Related]  

  • 11. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings assessments of the past and standards for the future.
    Dehmer GJ; Douglas JS; Abizaid A; Berg JW; Day J; Hall R; Leon MB; Hijazi ZM; Marchlinski F; Park SJ; Popma JJ
    Heart Rhythm; 2010 Oct; 7(10):1522-35. PubMed ID: 20869627
    [No Abstract]   [Full Text] [Related]  

  • 12. Interventional cardiology.
    Douglas JS
    J Am Coll Cardiol; 2005 Jun; 45(11 Suppl B):4B-8B. PubMed ID: 15936641
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory considerations for a traumatic brain injury (TBI) indication for hyperbaric oxygen (HBO2).
    Weaver LK; Dicks C; Deru K; Miller RS
    Undersea Hyperb Med; 2013; 40(5):439-41. PubMed ID: 24224287
    [No Abstract]   [Full Text] [Related]  

  • 14. Walking the drug regulatory tightrope.
    Dove A
    Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigational new drug application (IND).
    Hall J; Dib N
    J Cardiovasc Transl Res; 2008 Sep; 1(3):183-4. PubMed ID: 20559913
    [No Abstract]   [Full Text] [Related]  

  • 17. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory affairs as they affect invasive cardiology.
    Fischell RE
    J Invasive Cardiol; 2001 Feb; 13(2):139-40; discussion 158-70. PubMed ID: 11176026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; reclassification of six cardiovascular preamendments class III devices into class II. Final rule.
    Food and Drug Administration
    Fed Regist; 2001 Apr; 66(69):18540-2. PubMed ID: 11721689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approval does not mean what you think it does!
    Dorros G
    J Invasive Cardiol; 2010 Aug; 22(8):382-4. PubMed ID: 20679676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.